FTDI
RPRX icon

First Trust Direct Indexing’s Royalty Pharma RPRX Stock Holding History

First Trust Direct Indexing’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-26,847
Closed -$760K – 726
2024
Q3 		$760K Buy
26,847
+7,817
+41% +$217K 0.04% 430
2024
Q2 		$502K Sell
19,030
-2,619
-12% -$72.6K 0.03% 504
2024
Q1 		$657K Buy
21,649
+104
+0.5% +$3.07K 0.05% 396
2023
Q4 		$605K Buy
21,545
+5,501
+34% +$151K 0.05% 401
2023
Q3 		$435K Buy
+16,044
New +$477K 0.05% 430

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Trust Direct Indexing's RPRX Position: Q4 2024 in Review

First Trust Direct Indexing sold out of Royalty Pharma (RPRX) in Q4 2024, closing a stake of 26,847 shares — an estimated $760K sold.

First Trust Direct Indexing first reported a position in RPRX in Q3 2023 and held it in 5 quarters. The position peaked at $760K in Q3 2024. 417 funds tracked by Wall St. Rank hold RPRX as of Q4 2024.

  • First Trust Direct Indexing reported no remaining Royalty Pharma position as of Q4 2024 after selling out during the quarter.
  • First Trust Direct Indexing sold 26,847 Royalty Pharma shares in Q4 2024, an estimated $760K.
  • First Trust Direct Indexing first reported a position in Royalty Pharma in Q3 2023 and held it in 5 quarters.
  • First Trust Direct Indexing's Royalty Pharma position peaked at $760K in Q3 2024.
  • 417 funds tracked by Wall St. Rank held Royalty Pharma as of Q4 2024.

Based on First Trust Direct Indexing's 13F filing for Q4 2024.